These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 37388610)

  • 1. Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness.
    Chaudhuri M; Hassan Y; Bakka Vemana PPS; Bellary Pattanashetty MS; Abdin ZU; Siddiqui HF
    Cureus; 2023 May; 15(5):e39624. PubMed ID: 37388610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related macular degeneration.
    Lim LS; Mitchell P; Seddon JM; Holz FG; Wong TY
    Lancet; 2012 May; 379(9827):1728-38. PubMed ID: 22559899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related macular degeneration and myeloproliferative neoplasms - A common pathway.
    Liisborg C
    Acta Ophthalmol; 2022 Oct; 100 Suppl 271(Suppl 271):3-35. PubMed ID: 36200281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Imaging Macular Atrophy for Late-Stage Age-Related Macular Degeneration.
    Cheng AMS; Chalam KV; Brar VS; Yang DTY; Bhatt J; Banoub RG; Gupta SK
    Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects.
    Danis RP; Lavine JA; Domalpally A
    Clin Ophthalmol; 2015; 9():2159-74. PubMed ID: 26640366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration.
    ElSheikh RH; Chauhan MZ; Sallam AB
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors.
    Camelo S; Latil M; Veillet S; Dilda PJ; Lafont R
    Oxid Med Cell Longev; 2020; 2020():4984927. PubMed ID: 33520083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.
    Banister K; Cook JA; Scotland G; Azuara-Blanco A; Goulão B; Heimann H; Hernández R; Hogg R; Kennedy C; Sivaprasad S; Ramsay C; Chakravarthy U
    Health Technol Assess; 2022 Jan; 26(8):1-142. PubMed ID: 35119357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
    Marshall LL; Roach JM
    Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Options Under Development for Nonneovascular Age-Related Macular Degeneration and Geographic Atrophy.
    Kim JB; Lad EM
    Drugs Aging; 2021 Jan; 38(1):17-27. PubMed ID: 33355716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of age-related macular degeneration at first presentation in Bhutan: a 3-year national study.
    Rai BB; Morley MG; Bernstein PS; Maddess T
    BMC Ophthalmol; 2022 Jul; 22(1):298. PubMed ID: 35810276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye.
    Abdelfattah NS; Zhang H; Boyer DS; Rosenfeld PJ; Feuer WJ; Gregori G; Sadda SR
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1839-46. PubMed ID: 27082298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress on retinal image analysis for age related macular degeneration.
    Kanagasingam Y; Bhuiyan A; Abràmoff MD; Smith RT; Goldschmidt L; Wong TY
    Prog Retin Eye Res; 2014 Jan; 38():20-42. PubMed ID: 24211245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.
    Gehrs KM; Anderson DH; Johnson LV; Hageman GS
    Ann Med; 2006; 38(7):450-71. PubMed ID: 17101537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Updates on the Diagnosis and Management of Age-Related Macular Degeneration.
    Boopathiraj N; Wagner IV; Dorairaj SK; Miller DD; Stewart MW
    Mayo Clin Proc Innov Qual Outcomes; 2024 Aug; 8(4):364-374. PubMed ID: 39036487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging.
    Bowes Rickman C; Farsiu S; Toth CA; Klingeborn M
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(14):ORSF68-80. PubMed ID: 24335072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration-the PINNACLE trial protocol.
    Sutton J; Menten MJ; Riedl S; Bogunović H; Leingang O; Anders P; Hagag AM; Waldstein S; Wilson A; Cree AJ; Traber G; Fritsche LG; Scholl H; Rueckert D; Schmidt-Erfurth U; Sivaprasad S; Prevost T; Lotery A
    Eye (Lond); 2023 Apr; 37(6):1275-1283. PubMed ID: 35614343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related macular degeneration.
    Cheung LK; Eaton A
    Pharmacotherapy; 2013 Aug; 33(8):838-55. PubMed ID: 23580402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation studies of ranibizumab for neovascular age-related macular degeneration.
    Bloch SB
    Acta Ophthalmol; 2013 Nov; 91 Thesis7():1-22. PubMed ID: 24206851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression from intermediate to neovascular age-related macular degeneration according to drusen subtypes: Bundang AMD cohort study report 3.
    Kim KL; Joo K; Park SJ; Park KH; Woo SJ
    Acta Ophthalmol; 2022 May; 100(3):e710-e718. PubMed ID: 34390191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.